<DOC>
	<DOCNO>NCT01998477</DOCNO>
	<brief_summary>The study design evaluate safety TIVa TIVb vaccine child 3 &lt; 18 year age risk complication influenza disease due underlying disease .</brief_summary>
	<brief_title>A Study Evaluate Safety Two Influenza Vaccines Children Adolescents 3 &lt; 18 Years Age Risk Influenza-Related Complications</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals 3 17 year age underlying medical condition indicate increase risk complication influenza infection . Further eligibility criterion may discuss contact site ( ) Individuals fatal prognosis underlie medical condition ( &lt; 12 month life expectancy ) . Individuals hospitalize time enrolment . Individuals history anaphylaxis , serious vaccine reaction , hypersensitivity vaccine component . Further eligibility criterion may discuss contact site ( )</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Flu</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
</DOC>